Document is current
Any future updates will be listed below
-
Authors
Liu, Yuan
He, Shiyang https://orcid.org/0000-0002-1849-2635
Pyo, Kawon https://orcid.org/0009-0004-4001-384X
Franklin, Reuben https://orcid.org/0000-0002-6513-3205
Maaz, Ibrahim B.
Cai, Chen https://orcid.org/0009-0005-6964-9208
Shah, Kriti
Cheloufi, Sihem https://orcid.org/0000-0002-1726-4796
Marzluff, William F. https://orcid.org/0000-0003-3635-4073
Murn, Jernej https://orcid.org/0000-0002-1729-5859
-
Funding
Funding for this research was provided by:
National Science Foundation (2054195, 2054195)
U.S. Department of Health & Human Services | National Institutes of Health (GM29832)
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 26 May 2025
First Online: 18 June 2025
Competing interests
: J.M., W.F.M., and S.C. are inventors on a patent application filed by The Regents of the University of California (U.S. Provisional Patent Application No. 63/581,832) describing the methods of inducing reversible proliferative arrest presented in the manuscript. J.M. and S.C. are the founders of StopTime Inc., a startup focused on identifying and developing methods and compounds for the induction of cell dormancy and hypometabolism. All authors declare no other competing interests.
